NB-Bioglim VG2 is a combination tablet containing Metformin Hydrochloride (SR), Glimepiride, and Voglibose, used for the management of type 2 diabetes. Metformin (SR) helps reduce blood sugar by improving insulin sensitivity and reducing glucose production in the liver. Glimepiride stimulates insulin release from the pancreas, while Voglibose inhibits the breakdown of carbohydrates, helping to prevent post-meal blood sugar spikes. This triple-action formula effectively controls blood glucose levels, offering better glycemic control and improving overall diabetes management.



Reviews
There are no reviews yet.